Skip to main content
S 1049 115th Congress Senate Health Drug safety, medical device, and laboratory regulation Drug therapy Health personnel

Opioid Addiction Risk Transparency Act

Introduced: May 4, 2017 Introduced by: Hassan, Margaret Wood Democratic · New Hampshire See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 4, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 4, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Opioid Addiction Risk Transparency Act

This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
What's happening now May 4, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • S 934 Related bill FDA Reauthorization Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Young, Todd
Indiana · May 4, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1049: Opioid Addiction Risk Transparency Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-1049/
MLA
"S. 1049: Opioid Addiction Risk Transparency Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1049/.
Bluebook (legal)
S. 1049, 115th Cong. (2026), https://openamerica.io/bill/115-S-1049/.
Markdown link
[S. 1049: Opioid Addiction Risk Transparency Act](https://openamerica.io/bill/115-S-1049/)
Report a problem